HLA DR1/3/4/5, DQ intermediate resolution-994

Test info

  
HLA DR1/3/4/5, DQ intermediate resolution
  
994
  
LAB994
  
MSO
  

HLA antigens may be correlated with certain disease states or other clinical conditions. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.

Specimen

  
EDTA whole blood
  
  
7 mL
  
3.0 mL
  

Immediately following collection, mix sample thoroughly by gently inverting 8 - 10, times to prevent clotting

  

Lavender (EDTA) tube, 10mL

  

Indicate which antigen(s) is of interest

  

Ambient (preferred)

Frozen - NO

Protect from extreme heat or cold

  
  • Hemolyzed specimen
  • Clotted specimen
  • Wrong specimen container

Performance

  
LabCorp Burlington (167120): R-NX
  
Daily
  
5 - 7 days
  

Sequence-based typing (SBT), sequence-specific oligonucleotide probes (SSOP), and/or sequence-specific primers (SSP) as needed to obtain the required resolution.

Clinical and Interpretive info

  

An interpretive report will be provided

Billing

  
This test may require preauthorization from the insurance provider. Check the payer guidelines and, if needed, obtain the pre-authorization prior to sample collection.
  
81375
  
Yes
  
Result 57298-2
  

Medical necessity

Hospital clients submitting a request for this assay on an outpatient with Medicare should complete and submit a Molecular Medical billing request form along with the sample.

  • Complete and submit the form to notify us of the need for Allina Health Laboratory to bill insurance for Molecular testing performed
  • All information requested is required in order for your request to be completed

Molecular Medicare billing request

Tracking

  
05/29/2019
  
06/22/2023
  
03/30/2022